US Billionaire Launched New Generation Vaccine Manufacturing Plant in South Africa Based on Cancer Immunotherapy
On Jan. 19, 2022, South African-born U.S. biotech billionaire Patrick Soon-Shiong launched a vaccine manufacturing plant in the…
-
-
Pfizer-BioNTech COVID-19 vaccine received FDA Emergency Use Authorization for children 6 months through 4 years of age
On Jun. 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration (FDA) had granted emergency…
-
Moderna received FDA authorization for EUA of Its COVID-19 vaccine for children 6 months of age and older
On Jun. 17, 2022, the U.S. Food and Drug Administration (FDA) authorized emergency use of the Moderna COVID-19…
-
Pfizer and BioNTech provided update on rolling submission to EMA for potential variant-adapted vaccine
On Jun. 15, 2022, Pfizer and BioNTech announced the European Medicines Agency (EMA) had initiated a rolling review…
-
Oragenics announced publication of positive data for NT-CoV2-1 intranasal COVID-19 vaccine candidate in Scientific Reports
On Jun. 14 2022, Oragenics announced the publication of an article co-authored by Oragenics and collaborators at Inspirevax…
-
Novavax COVID-19 vaccine Nuvaxovid provisionally registered in Australia as booster in individuals aged 18 and over
On Jun. 13 2022, Novavax announced that the Australian Therapeutic Goods Administration (TGA) had granted provisional registration of…
-
Moderna announced Omicron-containing bivalent booster candidate mRNA-1273.214 demonstrated superior antibody response against Omicron
On Jun. 8, 2022, Moderna announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
USDA confirmed highly pathogenic Avian influenza in Georgia
On Jun. 2, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service confirmed the…
-
Moderna and the European Commission agreed on amendment to COVID-19 vaccine supply agreement
On Jun. 2, 2022, The European Commission and the vaccine developer Moderna announced they have reached an agreement…
-
Novavax filed in the UK for expanded conditional Marketing Authorization of COVID-19 vaccination booster in adult
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
-
Moderna and Takeda announced plans to transfer Marketing Authorization for Spikevax(TM) COVID-19 vaccine in Japan
On May 31, 2022, Moderna and Takeda announced the transfer of the marketing authorization for Moderna’s COVID-19 vaccine…
-
Novavax initiated phase 3 trial of its COVID-19 Omicron strain vaccine as a booster
On May 31, 2022, Novavax announced the initiation of its Phase 3 strain change trial to determine if…
-
Hong Kong Center for Health Protection notified late of 2nd H3N8 case on the mainland
On May 30, 2022, The Centre for Health Protection (CHP) of the Department of Health received notification from…
-
Roche developed unique PCR tests to detect the mpox virus
On May 25, 2022, Roche and its subsidiary TIB Molbiol announced they had developed three unique LightMix Modular…
-
Novavax participated in Oxford University Com-COV3 booster trial of COVID-19 vaccines in adolescents aged 12 through 15
On May 25, 2022, Novavax announced it was participating in a stage of the COVID-19 Vaccine Schedule Combinations…
-
Pfizer-BioNTech COVID-19 vaccine demonstrated strong immune response in children 6 months to under 5 years of age following third dose
On May 25, 2022, Pfizer and BioNTech announced topline safety, immunogenicity and vaccine efficacy data from a Phase…
-
WHO announced nulti-country mpox outbreak in non-endemic countries
On May 21, 2022, the World Health Organization (WHO) announced that since May 13, 2022, cases of mpox…
-
Novavax filed in the EU for expanded conditional Marketing Authorization of COVID-19 vaccine as booster in individuals aged 18 and over
On May 20, 2022, Novavax announced the submission of a request to the European Medicines Agency (EMA) to…
-
WHO validated 11th vaccine for COVID-19
On May 19, 2022, World Health Organization (WHO) issued an emergency use listing (EUL) for CONVIDECIA, a vaccine…
-
CDC and health partners responded to Mpox case in the U.S.
On May 18, 2022, scientists at the Centers for Disease Control and Prevention (CDC) announced that they were…
-
Study found ‘natural immunity’ from Omicron weak and limited
On May 18, 2022, researchers at Gladstone Institutes and UC San Francisco (UCSF) reported that unvaccinated people, infection…
-
IAVI and Moderna launched first-in-Africa clinical trial of mRNA HIV vaccine development program
On May 18, 2022, Moderna and the nonprofit scientific research organization IAVI announced that the first participant screenings…
-
USDA confirmed highly pathogenic Avian influenza in New Jersey
On May 18, 2022, the U.S. Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service (APHIS) confirmed…
-
Pfizer and BioNTech granted U.S. EUA for booster dose of COVID-19 vaccine in children 5 through 11 years of age
On May 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration expanded emergency use authorization…
-
Novavax filed for Emergency Use Authorization of COVID-19 vaccine in Taiwan
On May 13, 2022, Novavax announced the submission of a request for emergency use authorization to Taiwan’s Food…
-
WHO and Medicines Patent Pool announced agreement with NIH for COVID-19 health technologies
On May 12, 2022, the World Health Organization (WHO) COVID-19 Technology Access Pool and the Medicines Patent Pool…
-
NIH launched clinical trial of Epstein-Barr virus vaccine
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
-
Novavax’s COVID-19 vaccine Nuvaxovid arrived in Singapore
On May 6, 2022, Novavax announced that deliveries of it’s COVID-19 vaccine continued around the world and the…
-
Novavax submitted variations to expand Australian and New Zealand provisional approval of Nuvaxovid COVID-19 vaccine in Great Britain
On May 6, 2022, Novavax announced the submission of variations to the Australian Therapeutic Goods Agency (TGA) and…
-
Moderna finalized plan for long-term strategic partnership with the Government of Canada
On Apr. 29, 2022, Moderna announced its plan to build a state-of-the-art mRNA vaccine manufacturing facility in Quebec…
